Table 5. The most common medications taken together.
| Combination (ATC-4) | Support (%) | Lift |
|---|---|---|
| Platelet aggregation inhibitors excl. heparin (B01AC) + Organic nitrates (C01DA) | 20.78 | 2.01 |
| Platelet aggregation inhibitors excl. heparin (B01AC) + Beta-blocking agents, selective (C07AB) | 22.21 | 1.76 |
| Platelet aggregation inhibitors excl. heparin (B01AC) + HMG-CoA reductase inhibitors (C10AA) | 31.39 | 1.75 |
| HMG-CoA reductase inhibitors (C10AA) + Beta-blocking agents, selective (C07AB) | 21.68 | 1.68 |
| Platelet aggregation inhibitors excl. heparin (B01AC) + Angiotensin-II receptor blockers (ARBs), plain (C09CA) | 25.09 | 1.65 |
| HMG-CoA reductase inhibitors (C10AA) + Angiotensin-II receptor blockers (ARBs), plain (C09CA) | 25.02 | 1.61 |
| Vitamin D and analogues (A11CC) + Acetic acid derivatives and related substances (M01AB) | 20.77 | 1.58 |
| Acetic acid derivatives and related substances (M01AB) + Glucocorticoids (H02AB) | 27.33 | 1.48 |
| Third-generation cephalosporins (J01DD) + Glucocorticoids (H02AB) | 22.77 | 1.42 |
| Anilides (N02BE) + Glucocorticoids (H02AB) | 25.13 | 1.41 |
ATC, Anatomical Therapeutic Chemical classification.